Evaluating the Safety and Effectiveness of Liraglutide in Subjects With Type 2 Diabetes

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

4121 participants

Study Classification

OBSERVATIONAL

Study Start Date

2011-07-19

Study Completion Date

2015-12-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This trial is conducted in Asia. The aim of the trial is to assess the incidence rate and type of SADRs (serious adverse drug reactions).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Safety and Tolerability of Liraglutide in Japanese Subjects With Type 2 Diabetes

NCT01615978

Diabetes Diabetes Mellitus, Type 2

COMPLETED PHASE1

Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes

NCT00333151

Diabetes Diabetes Mellitus, Type 2

COMPLETED PHASE3

Effect of Liraglutide on Blood Glucose Control in Japanese Subjects With Type 2 Diabetes

NCT00154414

Diabetes Diabetes Mellitus, Type 2

COMPLETED PHASE2

Efficacy and Safety of Liraglutide in Combination With Insulin Therapy Compared to Insulin Alone in Japanese Subjects With Type 2 Diabetes

NCT01572740

Diabetes Diabetes Mellitus, Type 2

COMPLETED PHASE3

Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) Assessment of LIK066 in Healthy Subjects and in Patients With Type 2 Diabetes Mellitus (T2DM)

NCT01407003

Type 2 Diabetes Mellitus (T2DM)

COMPLETED PHASE1/PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diabetes Diabetes Mellitus, Type 2

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Liraglutide

liraglutide

Intervention Type DRUG

Once daily at a fixed timing, and subcutaneously (under the skin) in the abdomen, in the thigh or in the upper arm

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

liraglutide

Once daily at a fixed timing, and subcutaneously (under the skin) in the abdomen, in the thigh or in the upper arm

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subjects with type 2 diabetes mellitus, including newly-diagnosed subjects, who require treatment with liraglutide

Exclusion Criteria

* Subjects who are or have previously been on liraglutide
* Subjects who have previously been enrolled in the study
* Subjects with a hypersensitivity to liraglutide or to any of the excipients
* Subjects who are pregnant, breast feeding or have the intention of becoming pregnant within the study periods
* Subjects with cancer (except basal cell skin cancer or squamous cell skin cancer) or any clinically significant disorder, except for conditions associated with type 2 diabetes mellitus history which in the physicians' opinion could interfere with the results of the trial
* Known or suspected abuse of alcohol or narcotics

Eligible Sex

ALL

Accepts Healthy Volunteers

No